adapalene vs fluorouracil topical
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adapalene and fluorouracil topical. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Differin
Efudex
No summary available.
Fluorouracil topical (Efudex) is a skin cream that treats certain skin conditions. It belongs to a class of drugs called topical antimetabolites.
Information not available.
This medicine treats skin growths called actinic or solar keratoses. These are rough, scaly patches of skin caused by too much sun. It can also treat superficial basal cell carcinomas, a type of skin cancer.
Information not available.
Fluorouracil stops cells from growing. It mainly affects fast-growing cells like those in skin growths or cancers. This helps to remove the abnormal skin cells.
- • Dry skin
- • Contact dermatitis (skin rash)
- • Burning feeling on the skin where you put the medicine
- • Skin irritation
- • Redness
- • Burning
- • Itching
- • Pain
- • Swelling
- Dry Skin 44,990
- Skin Burning Sensation 41,633
- Acne 39,264
- Erythema 38,379
- Skin Irritation 26,225
No adverse event reports.
No specific warnings noted.
The treated skin can become very red, swollen, and uncomfortable. Tell your doctor if these symptoms become severe. This medicine can also make your skin more sensitive to the sun. Avoid sunlight or wear protective clothing and sunscreen.
No pregnancy information available.
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. This medicine may harm an unborn baby. It is not known if this medicine passes into breast milk.
Also Compare, Nearby Drugs
Compare adapalene with
How to Read This adapalene vs fluorouracil topical Comparison
adapalene is classified in the Retinoid (Topical) drug class, while fluorouracil topical sits within the Topical Antimetabolite class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adapalene has 190,491 submissions while fluorouracil topical has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adapalene or fluorouracil topical.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.